ARK Invest Reenters Alibaba With $16M Stake After Four-Year Hiatus

ARK Invest, led by Cathie Wood, has renewed its investment in Chinese tech giant Alibaba after a four-year hiatus, purchasing approximately $16.3 million in American Depositary Receipts amid a near doubling of the stock's value in 2025. This move reflects growing optimism around Alibaba's advancements in artificial intelligence and investor confidence in the company's ability to revitalize growth despite competitive pressures in e-commerce. Alongside Alibaba, ARK has increased its stake in Baidu to about $47 million, further signaling its strategic return to Chinese technology stocks following market volatility and regulatory challenges experienced in 2021 and 2022. ARK's ETFs also hold smaller positions in other Chinese tech-related companies such as BYD, Pony.ai, and JD Logistics, highlighting a diversified interest in the sector. Separately, ARK has expanded its holdings in Arcturus Therapeutics, a biotech firm specializing in RNA medicines for rare diseases, despite the company's financial challenges, underscoring ARK's continued commitment to innovative and high-growth potential sectors.